Table 2.
ICC (95 % CI) between each shorter trials and the 15 min trial | |||||||
---|---|---|---|---|---|---|---|
Trial 1 | Trial 2 | Trial 3 | Trial 4 | Trial 5 | First 150 from 15-min | ||
HY | Mean | 0.35 (−0.22 – 0.73) | 0.34 (−0.25 – 0.73) | 0.34 (−0.25 – 0.73) | 0.24 (−0.35 – 0.66) | 0.23 (−0.36 – 0.68) | 0.99 (0.97 – 1.00) |
CV | 0.37 (−0.21 – 0.75) | 0.31 (−0.17 – 0.70) | 0.53 (0.00 – 0.82) | 0.34 (−0.24 – 0.73) | 0.42 (−0.16 – 0.77) | 0.89 (0.63 – 0.96) | |
α-DFA | −0.38 (−0.82 – 0.21) | 0.06 (−0.49 – 0.56) | −0.23 (−0.72 – 0.35) | 0.28 (−0.24 – 0.70) | −0.03 (−0.51 – 0.48) | 0.42 (−0.15 – 0.77) | |
HE | Mean | 0.90 (0.72 – 0.97) | 0.96 (0.88 – 0.99) | 0.95 (0.85 – 0.98) | 0.94 (0.83 – 0.98) | 0.98 (0.95 – 0.99) | 0.99 (0.98 – 1.00) |
CV | 0.52 (0.01 – 0.82) | 0.31 (−0.18 – 0.70) | 0.25 (−0.26 – 0.68) | 0.74 (0.35 – 0.91) | 0.52 (−0.01 – 0.82) | 0.90 (0.45 – 0.97) | |
α-DFA | 0.30 (−0.30 – 0.71) | 0.07 (−0.40 – 0.55) | −0.07 (−0.53 – 0.44) | 0.46 (−0.03 – 0.78) | 0.33 (−0.21 – 0.72) | 0.77 (0.42 – 0.92) | |
PD | Mean | 0.73 (0.30 – 0.91) | 0.41 (−0.20 – 0.79) | 0.52 (−0.06 – 0.83) | 0.65 (0.16 – 0.89) | 0.46 (−0.14 – 0.81) | 0.98 (0.93 – 0.99) |
CV | 0.06 (−0.52 – 0.60) | 0.18 (−0.46 – 0.67) | 0.70 (0.27 – 0.90) | 0.14 (−0.49 – 0.65) | 0.21 (−0.38 – 0.69) | 0.58 (0.08 – 0.85) | |
α-DFA | 0.10 (−0.47 – 0.61) | −0.17 (−0.73 – 0.45) | 0.36 (−0.25 – 0.76) | 0.23 (−0.41 – 0.70) | 0.04 (−0.54 – 0.59) | 0.76 (0.38 – 0.92) |
HY Healthy young, HE Healthy elderly, PD Parkinson’s disease, CV Coefficient of variation, DFA Detrended fluctuation analysis, ICC Intraclass correlation.